NO20005148L - FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider - Google Patents

FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider

Info

Publication number
NO20005148L
NO20005148L NO20005148A NO20005148A NO20005148L NO 20005148 L NO20005148 L NO 20005148L NO 20005148 A NO20005148 A NO 20005148A NO 20005148 A NO20005148 A NO 20005148A NO 20005148 L NO20005148 L NO 20005148L
Authority
NO
Norway
Prior art keywords
glyoxamides
indole
substituted
preparing
Prior art date
Application number
NO20005148A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005148D0 (no
Inventor
Benjamin Alan Anderson
Nancy Kay Harn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20005148D0 publication Critical patent/NO20005148D0/no
Publication of NO20005148L publication Critical patent/NO20005148L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20005148A 1998-04-17 2000-10-13 FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider NO20005148L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8211098P 1998-04-17 1998-04-17
PCT/US1999/008332 WO1999054300A1 (en) 1998-04-17 1999-04-15 Process for preparing 4-substituted-1h-indole-3-glyoxamides

Publications (2)

Publication Number Publication Date
NO20005148D0 NO20005148D0 (no) 2000-10-13
NO20005148L true NO20005148L (no) 2000-11-09

Family

ID=22169126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005148A NO20005148L (no) 1998-04-17 2000-10-13 FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider

Country Status (27)

Country Link
US (1) US6265591B1 (de)
EP (1) EP1071663A4 (de)
JP (1) JP2002512225A (de)
KR (1) KR20010042741A (de)
CN (1) CN1305459A (de)
AR (1) AR015767A1 (de)
AU (1) AU750368B2 (de)
BR (1) BR9909697A (de)
CA (1) CA2326515A1 (de)
CO (1) CO5080803A1 (de)
DZ (1) DZ2770A1 (de)
EA (1) EA003582B1 (de)
EG (1) EG22139A (de)
HK (1) HK1039120A1 (de)
HR (1) HRP20000685A2 (de)
HU (1) HUP0101344A3 (de)
ID (1) ID26021A (de)
IL (1) IL138827A0 (de)
NO (1) NO20005148L (de)
NZ (1) NZ507175A (de)
PE (1) PE20000430A1 (de)
PL (1) PL343487A1 (de)
SK (1) SK15372000A3 (de)
SV (1) SV1999000043A (de)
TR (1) TR200002999T2 (de)
WO (1) WO1999054300A1 (de)
ZA (1) ZA200005294B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407261B1 (en) 1998-04-17 2002-06-18 Eli Lilly And Company Process for preparing 4-hdyroxy indole, indazole and carbazole compounds
EP1071661A4 (de) * 1998-04-17 2001-08-22 Lilly Co Eli Verfahren zur herstellung von 4-hydroxyindol-, indazol- und carbazol-verbindungen
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
US20030225149A1 (en) * 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
CN104042617A (zh) 2009-04-29 2014-09-17 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2341045A1 (de) 1994-04-01 2011-07-06 Eli Lilly and Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]Essigsäure (acyloxy)alkyl oder ((alkoxycarbonyl)oxy)alkyl Ester als SPLA2 Inhibitor
EP1071661A4 (de) * 1998-04-17 2001-08-22 Lilly Co Eli Verfahren zur herstellung von 4-hydroxyindol-, indazol- und carbazol-verbindungen

Also Published As

Publication number Publication date
IL138827A0 (en) 2001-10-31
HUP0101344A2 (hu) 2001-09-28
NO20005148D0 (no) 2000-10-13
PL343487A1 (en) 2001-08-27
WO1999054300A1 (en) 1999-10-28
AU3564899A (en) 1999-11-08
US6265591B1 (en) 2001-07-24
TR200002999T2 (tr) 2001-01-22
JP2002512225A (ja) 2002-04-23
BR9909697A (pt) 2000-12-19
EP1071663A1 (de) 2001-01-31
HRP20000685A2 (en) 2001-10-31
EA200001076A1 (ru) 2001-04-23
ID26021A (id) 2000-11-16
CN1305459A (zh) 2001-07-25
DZ2770A1 (fr) 2003-12-01
PE20000430A1 (es) 2000-05-24
AR015767A1 (es) 2001-05-16
SV1999000043A (es) 2000-05-02
EP1071663A4 (de) 2002-06-19
HK1039120A1 (zh) 2002-04-12
CO5080803A1 (es) 2001-09-25
EG22139A (en) 2002-08-30
NZ507175A (en) 2002-12-20
EA003582B1 (ru) 2003-06-26
KR20010042741A (ko) 2001-05-25
AU750368B2 (en) 2002-07-18
SK15372000A3 (sk) 2001-08-06
HUP0101344A3 (en) 2002-12-28
ZA200005294B (en) 2001-10-01
CA2326515A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
AR024800A1 (es) Proceso de produccion de fenil-alcanos
ATE256097T1 (de) Trennungsverfahren
IS4828A (is) Aðferð við að framleiða N-asetýl-D-glúkósamín
ATE289577T1 (de) Trennungsverfahren
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
DE69901014D1 (de) Keilantriebsvorrichtung
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
DK0994091T3 (da) Fremgangsmåde til fremstilling methanol
DE69906880D1 (de) Bilderzeugungsverfahren
DE69901652D1 (de) Reinigungsverfahren
DE69938126D1 (de) Stranggussverfahren
DK1059290T3 (da) Process for producing canthaxanthin
FI991490A0 (fi) Visualisointimenetelmä
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
NO992797D0 (no) FremgangsmÕte for fremstilling av et eter-karboksylatsalt
NO20005148D0 (no) FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
IS5602A (is) Aðferð til að framleiða ál
TR199900757A3 (tr) Fenoksifenilsülfonil halidlerin hazirlanmasi için islem.
ID29194A (id) Metode untuk menguapkan aminonitril
SE9800255D0 (sv) New process
SE9800256D0 (sv) New process
SE9800735D0 (sv) New process

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application